Abstract
Autism spectrum disorder (ASD) is more prevalent in males than in females, but the neurobiological mechanisms that give rise to this sex-bias are poorly understood. The female protective hypothesis suggests that the manifestation of ASD in females requires higher cumulative genetic and environmental risk relative to males. Here, we test this hypothesis by assessing the additive impact of several ASD-associated OXTR variants on reward network resting-state functional connectivity in males and females with and without ASD, and explore how genotype, sex, and diagnosis relate to heterogeneity in neuroendophenotypes. Females with ASD who carried a greater number of ASD-associated risk alleles in the OXTR gene showed greater functional connectivity between the nucleus accumbens (NAcc; hub of the reward network) and subcortical brain areas important for motor learning. Relative to males with ASD, females with ASD and higher OXTR risk-allele-dosage showed increased connectivity between the NAcc, subcortical regions, and prefrontal brain areas involved in mentalizing. This increased connectivity between NAcc and prefrontal cortex mirrored the relationship between genetic risk and brain connectivity observed in neurotypical males showing that, under increased OXTR genetic risk load, females with ASD and neurotypical males displayed increased connectivity between reward-related brain regions and prefrontal cortex. These results indicate that females with ASD differentially modulate the effects of increased genetic risk on brain connectivity relative to males with ASD, providing new insights into the neurobiological mechanisms through which the female protective effect may manifest.
Subject terms: Autism spectrum disorders, Clinical genetics
Introduction
Across species, the neuropeptide oxytocin plays a critical role in a wide range of reproductive and complex social processes, including initiation of uterine contractions during childbirth, lactation, pair bonding, and social reward processing1,2. The effects of oxytocin are dependent on expression of its receptor throughout the brain and body, and several variants in the oxytocin receptor gene (OXTR) have been linked to increased rates of autism spectrum disorder (ASD)3–6. As social deficits are a core feature of ASD, the oxytocin system has attracted considerable attention as a potential target for pharmacological manipulation in individuals with autism7–9. Indeed, in males with ASD, treatment with intranasal oxytocin has been shown to improve social responsivity, seemingly through effects on reward-related subcortical brain areas and frontal brain regions important for social cognition10–16.
Given that males are about four times as likely to receive an ASD diagnosis as females17, it is not surprising that much of the research conducted to date on the neurobiological correlates of oxytocin functioning in individuals with ASD has been in males. However, sex-specific regulation of the oxytocin system has been reported in both animals18,19 and humans20, suggesting that findings in males may not be generalizable to females. Importantly, animal studies have shown sex-differences in OXTR expression in several brain regions important for social functioning and maternal behavior, with females displaying higher expression relative to males21,22, and that genetic variation in the OXTR affects the expression of receptors in subcortical brain areas important for social behavior23. The neurobiological effects of oxytocin suggest that it may have a protective effect by enhancing neural plasticity through induction of long term potentiation24–26 at synapses where the OXTR is expressed27,28, and by reducing neuroinflammation through inhibition of microglial activation27,29. This evidence for a role of oxytocin in modulating neuroplasticity and inflammation, as well as evidence for brain-based sex-differences in functioning of the oxytocin system, has led some to hypothesize that oxytocin may have a neuroprotective effect against the development of ASD in females30.
In the genetics literature, theories on the neurogenetic underpinnings of sex differences in ASD have hypothesized a female protective effect (FPE) whereby females require a higher burden of genetic and environmental risk factors to develop ASD31. Evidence for a FPE comes from research showing that females with ASD carry more deleterious copy number and single nucleotide variants relative to males with ASD32,33, and further that genes highly expressed in the male brain also tend to be upregulated in the brains of individuals with ASD34. Together, these studies suggest that the male-bias in ASD may be due to inherent differences in sex-specific neurobiology, which in turn affect the impact that ASD risk variants have on neuroendophenotypes34,35. At the neural systems level, sex differences in the capacity of the brain to adapt to genetic and environmental risk factors may mediate the effects of genetic risk for ASD on the brain and ultimately behavior36; indeed, genes involved in the regulation of synaptic plasticity have been associated with increased ASD risk37.
As multiple SNPs in the OXTR have been linked to higher rates of ASD3–6 and altered neural activity to rewards38, the oxytocin system serves as an ideal model in which to test whether increased genetic risk for ASD affects neural functioning in a dose-dependent manner. In the brain, the oxytocin receptor is expressed in subcortical areas, with enhanced expression in reward-related areas including the NAcc, hypothalamus, and substantia niagra39— regions which also show altered function and connectivity in individuals with ASD40–44. A recent imaging-genetics study of predominantly male youth with and without ASD showed that in the presence of increased genetic risk for ASD in the OXTR, youth with ASD display reduced connectivity between the NAcc and other subcortical brain regions critical for implicit learning and reward processing45. Conversely, typically developing youth with a greater number of ASD-associated variants in the OXTR gene display compensatory functional connectivity between the NAcc and prefrontal cortex, which may buffer them from expressing social cognitive deficits indicative of ASD45. However, researchers have yet to assess potential sex-differences in the dose-dependent relationship between genetic risk for ASD and neuroendophenotypes, and to investigate putative sex-dependent mechanisms of neural plasticity and resilience. Using data from a multisite study focused on gender differences in ASD, here we examined how ASD risk-allele-dosage in the OXTR relates to heterogeneity in NAcc network connectivity and, critically, investigate sex differences in the effects of genetic risk on the brain by comparing cohorts of males and females with and without ASD.
Methods
Subjects
Female participants were high functioning females with ASD (n = 50) and neurotypical (NT) females (n = 52) between the ages of 8 and 17 (M = 13.66, SD = 2.67) who were recruited from four sites (Harvard, Seattle Children’s Hospital, University of California, Los Angeles (UCLA), and Yale) as part of the Gender Exploration of Neurogenetics and Development to Advance Autism Research (GENDAAR) multisite consortium. Male participants were high-functioning males with ASD (n = 37) and NT males (n = 34) between the ages of 8 and 17 (M = 13.34, SD = 2.05) who were recruited from the Los Angeles area through the UCLA Center for Autism Research and Treatment (CART). Note that male subjects in the current study are the same as described in Hernandez et al.45; the sample in that study included several female participants (four ASD, seven NT), which were excluded in the current study where analyses were re-run in NT and ASD male-only subsamples. All previously reported results held (Supplementary Figs. 1, 2). The data is publicly available through the NIMH Data Archive (Collection ID 10 and 2021).
Participants with a history of claustrophobia, diagnosed neurological disorders, genetic conditions, structural brain abnormalities, or metal implants were excluded from study participation. Study protocols were approved by the Institutional Review Board at each participating site and informed consent and assent to participate in research were obtained from legal guardians and study participants. All participants with ASD had a prior diagnosis for the disorder based on the diagnostic and statistical manual of mental disorders46, which was confirmed using the Autism Diagnostic Observation Schedule—2nd Edition (ADOS-2)47, Autism Diagnostic Interview-Revised (ADI-R)48, and best clinical judgment by licensed clinicians at each participating site. Criterion for study inclusion was an IQ above 70 as assessed by the Differential Ability Scales II49, Wechsler Intelligence Scale for Children-IV50, or the Wechsler Abbreviated Scale of Intelligence51. Additional behavioral measures included the Social Responsiveness Scale (SRS)52, a measure that provides a quantitative index of autistic traits. The SRS is designed to assess reciprocal social behavior in both NT and ASD individuals ages 4–18 years; questionnaires were completed by parents of study participants. Seventeen ASD females and 18 ASD males reported use of one or more psychotropic medications (Supplementary Table 1). A summary of demographic information is presented in Table 1.
Table 1.
ASD Females | ASD Males | NT Females | NT Males | Females ASD vs. NT | Males ASD vs. NT | ASD Female vs. Male | NT Female vs. Male | |
---|---|---|---|---|---|---|---|---|
Age | 13.84 | 13.50 | 13.49 | 13.17 | 0.59 | 0.50 | 0.53 | 0.60 |
Full IQ | 97.91 | 105.24 | 112.97 | 106.26 | 0.001b | 0.72 | 0.08 | 0.03a |
Nonverbal IQ | 99.53 | 105.65 | 110.82 | 105.32 | 0.009b | 0.92 | 0.12 | 0.11 |
Verbal IQ | 101.16 | 103.73 | 111.18 | 107.09 | 0.018a | 0.23 | 0.50 | 0.19 |
ADOS social | 7.97 | 9.70 | – | – | – | – | 0.05a | – |
ADOS repetitive behavior | 2.06 | 2.29 | – | – | – | – | 0.57 | – |
ADOS severity score | 6.13 | 7.02 | – | – | – | – | 0.10 | – |
ADI social | 19.09 | 20.11 | – | – | – | – | 0.41 | – |
ADI Communication | 15.77 | 16.30 | – | – | – | – | 0.64 | – |
ADI repetitive behavior | 6.00 | 6.78 | – | – | – | – | 0.21 | – |
Mean relative motion | 0.12 | 0.08 | 0.09 | 0.08 | 0.16 | 0.27 | 0.02a | 0.10 |
Mean volumes scrubbed | 14.97 | 2.81 | 8.58 | 2.97 | 0.21 | 0.89 | 0.003b | 0.07 |
Mean OXTR risk variants | 3.44 | 3.30 | 3.45 | 3.12 | 0.94 | 0.47 | 0.58 | 0.19 |
Subjects with ≥1 risk allele | ||||||||
rs1042778 | 28 | 30 | 27 | 23 | 0.53 | 0.19 | 0.47 | 0.18 |
rs2254298 | 6 | 7 | 8 | 9 | 0.59 | 0.45 | 0.99 | 0.83 |
rs53576 | 21 | 20 | 21 | 12 | 0.87 | 0.11 | 0.33 | 0.02a |
rs237887 | 28 | 27 | 25 | 29 | 0.22 | 0.20 | 0.14 | 0.32 |
Self-reported ethnicity | ||||||||
Asian | 2 | 2 | 3 | 3 | 0.67 | 0.57 | 0.88 | 0.97 |
Black/African American | 0 | 2 | 3 | 6 | 0.08 | 0.10 | 0.18 | 0.31 |
Other/Mixed | 4 | 4 | 5 | 2 | 0.76 | 0.46 | 0.83 | 0.22 |
White | 26 | 25 | 22 | 19 | 0.18 | 0.31 | 0.20 | 0.37 |
Mean values and p-values derived from two-tailed independent samples t-tests or chi-squared tests. ap < 0.05; bp < 0.01.
ASD autism spectrum disorder, NT neurotypical, IQ intelligence quotient, ADOS Autism diagnostic observation schedule, ADI Autism Diagnostic interview, OXTR oxytocin receptor gene.
Genotyping
Genomic DNA from whole blood was obtained from the Rutgers University Cell and Data Repository (RUCDR) or extracted using standard protocols (Gentra Puregene Blood DNA extraction kit; Qiagen). Genotyping for SNPs rs237887 and rs1042778 was performed at Yale University or the UCLA Neuroscience Genomics Core (https://www.semel.ucla.edu/ungc) according to standard manufacturer protocols using the HumanOmni2.5-8 BeadChip microarray (Illumina Inc.) Commercially available TaqMan assays were used to genotype SNPs rs53576 and rs2254298 at the UCLA Genotyping and Sequencing Core (GenoSeq Core; http://genoseq.ucla.edu) using a 5′ nuclease assay to discriminate between the two alleles (Taqman SNP Genotyping Assay, Applied Biosystems Inc.). Polymerase chain reactions were performed using 5-μL reaction volumes in 384-well plates with 25 ng of DNA and Taqman genotyping master mix from Applied Biosystems Inc. End point reads of fluorescence levels were obtained with a Roche 480 lightcycler following manufacturer’s protocol. After quality filtering (<5% missing per person/per SNP, >1% minor allele frequency, Hardy-Weinberg equilibrium p > 10−7), multi-dimensional scaling was performed in PLINK (http://pngu.mgh.harvard.edu/purcell/plink/) using the default settings with the HapMap 3 reference panel (http://hapmap.ncbi.nlm.nih.gov/).
MRI data acquisition
Resting-state functional magnetic resonance imaging (rs-fcMRI) data were collected at each of the four GENDAAR participating sites on either a Siemens 3T Trio (12-channel head coil) or a Prisma 3T (20-channel head coil) whole-body scanner. For each subject, a T2*-weighted resting-state functional MRI sequence was acquired (6–8 min, TR = 2000ms, TE = 30 ms, FOV = 192 mm, 34 slices, slice thickness 4 mm, in-plane voxel size 3 × 3 mm for females; 6 min, TR = 3000 ms, TE = 28 ms, FOV = 192 mm, 34 slices, slice thickness 4 mm, in-plane voxel size 3 × 3 mm for males). For registration purposes, a matched-bandwidth echo-planar scan was also acquired (Siemens Trio: TR = 5000 ms, TE = 34 ms, FOV = 192 mm, 34 slices, slice thickness 4 mm, in-plane voxel size 1.5 × 1.5 mm; Siemens Prisma: identical parameters except for TE = 35 ms, 36 slices).
fMRI data analysis
The rs-fMRI data were analyzed using FSL (FMRIB’s Software Library, www.fmri.ox.ac.uk/fsl)53 and AFNI (Analysis of Functional NeuroImages)54. Data were processed using the same pipeline described in Hernandez et al.45 to ensure valid comparisons of results obtained for the male and female groups. Images were skull-stripped using AFNI. Next, FSL’s Motion Correction Linear Registration Tool (MCFLIRT)55 was used to align the functional images with the mean functional volume. Translations in the x, y, and z dimensions were calculated from volume to volume, then averaged to create a measure of mean displacement. Functional data were linearly registered to the matched-bandwidth EPI volume (6 degrees of freedom), followed by registration to the MNI 152 2 mm standard brain (12 degrees of freedom). FSL’s Automatic Segmentation Tool (FAST) was applied to high-resolution scans to create masks for grey matter, white matter, and cerebral spinal fluid for each subject; these variables, as well as the global signal were regressed from the data using FSL’s FEAT. Images were smoothed using a 5 mm FWHM Gaussian kernel. Bandpass filtering was applied to the data (0.1 Hz > t > 0.01 Hz).
Motion scrubbing was performed, including removal of volumes for which frame-wise displacement exceeded 0.5 mm and DVARS exceeded 0.5%; two volumes preceding and one volume following a scrubbed image were also removed56. Participants with <5 min of data after scrubbing were excluded from final analyses resulting in a final sample of 32 ASD females, 33 NT females, 37 ASD males, and 34 NT males. The mean number of volumes remaining after scrubbing were 176, 179, 117, and 117, for ASD females, NT females, ASD males, and NT males, respectively. There were no differences in the number of volumes remaining between ASD and NT females, or between ASD and NT males. There were significant differences in the mean number of volumes remaining between female and male participants (p < 0.01), thus, the number of remaining volumes after scrubbing for each participant was used as a covariate in group-level analyses comparing male and female youth. FSL’s FLIRT was used to register residuals from the motion scrubbed data to the EPI volume (6 degrees of freedom), followed by registration to the MNI 152 2 mm standard brain (12 degrees of freedom). Power calculations were conducted in G*Power 3.1;57 anticipated effect size estimates were obtained from previously published work assessing the effect of OXTR variants on reward network activity38. Sample sizes for males and females with and without ASD in the current study are sufficient to detect significant effects in each group at 80% power and a 0.05 significance level.
Statistical analyses were performed using the general linear model in FSL’s FEAT. The NAcc was defined bilaterally using the Harvard Oxford Atlas at a probability threshold of 25%. Average timeseries were extracted from the bilateral NAcc and correlated with every other voxel in the brain to generate functional connectivity maps for each participant. Individual subject-level correlation maps were transformed to z-statistic maps using Fisher’s r to z transform. Single-subject maps were combined in higher-level group analyses in FSL’s FEAT using FLAME 1 + 2, a mixed effects model. Female diagnostic groups (i.e., female ASD vs. NT) did not differ in age; however, as diagnostic groups differed in IQ and the number of participants who underwent MRI at each site (Table 1) these variables were used as covariates in group-level comparisons. Male diagnostic groups (i.e., male ASD vs. NT) did not show any between-group differences in demographic variables; accordingly, comparisons between male diagnostic groups did not include covariates. Results of NAcc whole-brain connectivity analyses are presented at z > 3.1 (p < 0.001), corrected for multiple comparisons at p < 0.05. Group-level analyses testing the interaction between sex and diagnostic status on NAcc connectivity were controlled for demographic variables on which male and female groups differed including MRI data collection site, IQ, and number of functional volumes remaining after motion scrubbing. Examination of sex differences in positive and negative NAcc connectivity focused on regions showing significant connectivity (z > 3.1, cluster-corrected at p < 0.05) in any group (NT females, NT males, ASD females, ASD males).
To assess the aggregate effect of OXTR genetic risk on NAcc connectivity, cumulative genetic risk scores were computed for each participant as the sum of the number of ASD-associated risk alleles across four OXTR SNPs: rs53576, rs237887, rs1042778, rs2254298 (Supplementary Table 2). Mean genetic risk was calculated across NT and ASD groups; subjects’ demeaned genetic risk score was entered as a regressor in higher-level FEAT analyses (FLAME 1 + 2). We previously demonstrated that none of the four SNPs contributed disproportionally to altered NAcc-resting state functional connectivity by iteratively assessing effects of three SNPs on brain connectivity in a leave-one-out fashion; results when assessing 3-SNP models were identical to the final 4-SNP model45. Modulation of NAcc connectivity by aggregate OXTR risk was assessed at z > 3.1, corrected for multiple comparisons at p < 0.05.
Results
Male results for both whole-brain NAcc connectivity and effects of OXTR risk variants mirrored those previously reported in a largely overlapping sample of ASD and NT participants45. Greater numbers of ASD-associated variants in the OXTR gene were associated with reduced within-network connectivity in males with ASD, and greater connectivity between the NAcc and prefrontal cortex in NT males (Supplementary Figs. 1, 2). Below, we first detail the results for females with and without ASD, and then examine the interaction between sex, diagnosis, and genetic risk for ASD in the OXTR.
OXTR genetic variation in females
In females, the average number of risk alleles in the OXTR was 3.45 (SD = 1.03, range 2–6); NT females had on average 3.45 OXTR risk alleles (SD = 1.03), ASD females had on average 3.44 OXTR risk alleles (SD = 1.05; Table 1). An independent samples t-test indicated that, as expected, there was not a significant difference in the average number of OXTR risk alleles in NT and ASD females. As previously reported in ASD males45, inheriting greater numbers of OXTR risk alleles was associated with higher calibrated severity scores on the ADOS in females with ASD (r = 0.29, one-tailed p = 0.05). There were no differences between males and females with and without ASD in the cumulative number of inherited OXTR risk-alleles (Table 1), nor any relationships between IQ or medication status and the number of ASD-associated OXTR risk alleles.
Female NAcc whole-brain connectivity
The NAcc showed significant connectivity with other key reward-related brain regions in both NT females and females with ASD (Fig. 1). Both groups showed positive connectivity between the NAcc and frontal pole, superior frontal gyrus, frontal medial and orbital cortex, paracingulate and cingulate cortex, caudate, and putamen; connectivity between NAcc and amygdala was observed in NT females only. Negative (anticorrelated) connectivity was observed between the NAcc and occipital cortex (lingual and fusiform gyri). Females with ASD displayed additional negative connectivity between the NAcc and sensorimotor brain regions (bilateral middle frontal gyrus and thalamus, left precentral gyrus, right pallidum and insula) and areas involved in auditory/language processing (i.e., middle temporal gyrus, angular gyrus, parietal operculum). These results lend support to findings previously reported in NT and ASD males, who showed positive connectivity between the NAcc and frontal cortex, anterior cingulate, bilateral caudate and putamen (with NT males having additional NAcc-precuneus positive connectivity), and negative connectivity to thalamus, occipital, and parietal cortex (Supplementary Figs. 1, 2)45. There were no significant differences between NT females and ASD females in NAcc whole-brain positive or negative connectivity.
Next, we compared whole-brain NAcc connectivity between males and females with and without ASD. Sex differences were observed in ASD youth; relative to ASD males, ASD females showed stronger negative connectivity between the NAcc and right lingual gyrus (MNI coordinates: 14, −64, −4; 105 voxels; max z = 4.33). No sex differences were observed when comparing NT males and females.
Cumulative genetic risk: effects on NAcc connectivity in females
In females with ASD, greater numbers of ASD-associated variants in the OXTR gene were associated with stronger connectivity between the NAcc and subcortical brain regions involved in implicit learning and sensory processing including the dorsal striatum (caudate, putamen) and thalamus, as well as weaker connectivity with visual cortex (Fig. 2a; Supplementary Table 3). We conducted exploratory analyses whereby parameter estimates of connectivity were extracted from these clusters and correlated with scores on the two ADOS subscales, as well as the Social Cognition subscale of the SRS. A Spearman rank-order correlation indicated that increased NAcc-subcortical connectivity in ASD females was related to higher RRB scores on the ADOS (rs = 0.42, p = 0.02; Fig. 2b); however, this finding did not survive correction for the number of tests performed (n = 6). Higher RRB scores in females with ASD also positively correlated with increased OXTR genetic risk (rs = 0.46, p = 0.01); however, NAcc-subcortical connectivity did not mediate the relationship between genetic risk and RRB.
In contrast, in NT females, increased genetic risk for ASD in the OXTR was associated with increased connectivity between the NAcc and frontal brain areas implicated in social cognition/mentalizing (i.e., frontal medial cortex, frontal pole), as well as sensory brain regions (pre/postcentral gyrus, occipital pole). As OXTR risk-allele dosage increased, NT females also showed reduced functional connectivity between the NAcc, anterior cingulate gyrus, paracingulate, superior frontal gyrus, and frontal pole (Fig. 2a; Supplementary Table 3).
Between-group comparisons revealed that aggregate OXTR risk differentially modulated NAcc connectivity in NT and ASD females in sensory brain regions (bilateral occipital cortex, postcentral gyrus, thalamus), as well as a region in the frontal pole implicated in working memory (Fig. 2c; Supplementary Table 3). These between-group differences held in a subsample of NT and ASD females matched for IQ (Supplementary Table 4). To confirm that results were not biased by ancestry, the first two components from multidimensional scaling of genome-wide data were controlled for in a correlation analysis between cumulative risk-allele dosage and parameter estimates extracted from brain regions modulated by OXTR risk at the whole-brain level; results in both NT and ASD females remained significant.
Cumulative genetic risk: sex-specific effects on NAcc connectivity
A significant OXTR risk-allele dosage by sex by diagnostic group ANCOVA indicated that the effects of OXTR in NT males vs. females differed from those observed in ASD males vs. females (Supplementary Fig. 3). To qualify these findings, simple two-way interactions were tested.
Sex significantly modulated the relationship between OXTR genetic risk and NAcc connectivity in the ASD group only. Relative to their male counterparts, as genetic risk for ASD increased, females with ASD showed significantly greater connectivity between the NAcc and regions of the mesolimbic reward system, including the caudate, pallidum, and putamen, as well as bilateral thalamus, right prefrontal cortex, and left medial prefrontal cortex (Fig. 3, Supplementary Table 5). This region of the left prefrontal cortex that showed greater connectivity with the NAcc in ASD females with high genetic risk (compared to ASD males with high risk) is the same region where NT males show stronger connectivity (compared to ASD males with high risk) as a function of increasing OXTR aggregate risk (Supplementary Fig. 2)45. Furthermore, previous work in NT males has shown that increased NAcc-left prefrontal connectivity is associated with better social cognition as measured by the SRS45. We thus had an a priori hypothesis that NAcc-left prefrontal connectivity would be related to scores on the SRS social cognition subscale. Indeed, in females with ASD, extracting parameter estimates indexing NAcc-left prefrontal connectivity showed that stronger reward-frontal cortex connectivity was related to better social cognition as measured by the SRS (r = −0.43, p = 0.02; Fig. 3). While OXTR risk allele-dosage was negatively correlated with SRS scores in females with ASD (rs = −0.4, p < 0.05), NAcc-left prefrontal connectivity did not mediate this relationship. Additional exploratory brain-behavior correlations with ADOS subscales and the social cognition subscale of the SRS were examined for clusters showing a sex-specific effect of OXTR risk-allele dosage (i.e., right prefrontal cortex and subcortical brain regions shown in Fig. 3); results were not significant.
Additional analyses were conducted to test the extent to which gene-brain-behavior patterns observed in ASD females and NT males were indeed similar. First, at the whole-brain level, aggregate OXTR risk differentially modulated NAcc connectivity in NT males vs. ASD females in subcortical but not in prefrontal brain regions (Supplementary Fig. 4). Second, parameter estimates were extracted from the left prefrontal brain areas where ASD females and NT males showed greater connectivity with the NAcc as a function of OXTR genetic risk relative to ASD males (i.e., ASD female > ASD male (Fig. 3) and NT male > ASD male (Supplementary Fig. 2)); a two-tailed t-test using these connectivity indices revealed no significant differences between ASD females and NT males (p = 0.26), indicating that connectivity between the NAcc and the left prefrontal cortex did not vary significantly between the two groups. Third, an analysis of covariance (ANCOVA), controlling for the same variables used in our original bottom-up between-group analyses, was used to test for homogeneity of regression slopes (i.e., the slope of the relationship between OXTR risk-allele dosage and NAcc-left prefrontal cortex connectivity) between ASD females and NT males; the Group × OXTR comparison was not significant (β = −0.06, SE = 0.04, t = −1.55, p = 0.13), indicating no significant differences in slopes between ASD females and NT males.
Discussion
Here, we report that common variants in the OXTR modulate reward network functional connectivity in both a sex- and diagnosis-dependent manner. Directly comparing males and females with ASD, we found sex-specific associations between OXTR variants and brain circuitry such that in the presence of increased genetic risk, females showed greater connectivity between the reward network and prefrontal brain regions important for social cognition and inhibitory control, whereas males showed the opposite pattern. Further, in females with ASD, greater NAcc connectivity with left prefrontal regions was also associated with better functioning on the social cognition subscale of the SRS. Remarkably, these gene-brain-behavior results directly mirror our previously reported findings in NT males, who showed the same pattern whereby NAcc-left prefrontal connectivity increased as a function of increased OXTR risk-allele-dosage and was related to better social cognition scores on the SRS45. These findings suggest that the relationship between OXTR genetic risk and brain connectivity in females with ASD, rather than being more similar to ASD males, are more akin to neurotypical males both in terms of reward network-frontal connectivity and brain-behavior relationships. These findings are in agreement with a female protective model of ASD susceptibility in which ASD risk variants (such as those in the OXTR) interact with other genes that are expressed in a sex-differential and regionally-specific manner throughout the brain, resulting in the manifestation of sex-specific neuroendophenotypes in individuals with ASD. Gene expression analyses in post-mortem human brain samples have shown that individuals with ASD (compared to neurotypical individuals) and males (compared to females) show downregulation of genes with neural and synaptic functions, as well as upregulation of genes involved in neuroimmune and inflammatory processes34,58. Thus, male-typical gene expression profiles may create a background on which ASD-risk genes are likely to have more penetrant/deleterious effects whereas female gene expression profiles may act to buffer the effects of ASD-risk variants on neural circuitry34. Our data support this theory, as we found that cumulative genetic risk for ASD in the OXTR has more penetrant effects on connectivity within the reward network in males with ASD compared to NT males45, and that females with ASD may be in part buffered from the neurobehavioral effects of high OXTR genetic risk through formation of compensatory NAcc-prefrontal connectivity. Interestingly, behavioral research suggests that high functioning females with ASD show greater social motivation compared to their male counterparts59–61, a finding which has been attributed to the ability of females with higher IQ to mask their social-communicative deficits60,62. Our findings of increased connectivity between brain regions involved in reward processing and prefrontal brain areas important for metalizing in high functioning females with ASD may provide a neurobiological mechanism supporting this behavioral process.
A second feature of ASD females that distinguished them from both ASD males and NT females was that higher OXTR risk was related to greater connectivity between the NAcc and subcortical brain regions, a pattern not observed in any other group. Subcortical brain areas in the striatum are known to play a critical role in implicit learning of motor repertoires through cortico-basal ganglia feedback circuits63,64, and indeed this increased NAcc-subcortical connectivity was associated with higher restricted interests and repetitive behavior (RRB) scores on the ADOS in females with ASD. Notably, a sex-bias in expression of repetitive behaviors has been documented in individuals with ASD whereby males generally display more repetitive behaviors and restricted interests relative to females65. Our imaging-genetics results in ASD females suggest that increased genetic risk in the OXTR, as well as associated up-regulation of connectivity between the reward network and subcortical brain regions, may put ASD females at a greater likelihood of expressing RRBs. Although females in our study did not display more severe RRB than males with ASD, we also did not see the typical pattern whereby males with ASD show higher RRB relative to females.
That the OXTR risk variants investigated in this study would affect frontal and subcortical brain regions in a sex-specific manner are in line with findings from studies using intranasal oxytocin to alter neural activity. In adult neurotypical females, administration of intranasal oxytocin increases connectivity between subcortical brain regions involved in reward and social-emotional processing, and, importantly the effects of oxytocin are greatest in women with higher autistic traits39. Sex differences in the effects of intranasal oxytocin have been documented in neurotypical adults such that oxytocin increases brain activity in the caudate and putamen in men, while decreasing activity in these brain regions in women66. Furthermore, these sex-dependent effects of oxytocin on the brain interact with genetic variants in the OXTR. For instance, for the rs53576 SNP on which the A allele has been associated with increased rates of ASD diagnosis, male GG homozygotes (i.e., the non-risk group) show greater caudate activity during a game eliciting social cooperation under oxytocin vs. placebo, while female GG carriers have greater caudate activity in the placebo condition67. Similarly, for the rs1042778 SNP for which the G allele confers ASD-risk, male TT homozygotes (i.e., the non-risk group) display greater increases in amygdala activity in response to angry faces compared to risk-allele carriers, while no significant difference is observed between female risk and non-risk groups68. How these results may translate to males and females with ASD and how the modulatory effects of oxytocin may be affected by cumulative genetic risk for ASD in the OXTR have yet to be empirically determined. Taken together with previous data, our findings suggest that in addition to investigating the effect of sex on oxytocin treatment outcomes, it is critical that future work also consider sex x diagnosis interactions, as ASD males and females are likely to show different neural responses, at baseline and in response to treatment, from their NT male and female counterparts. Notably, recent research suggests that the effects of oxytocin on neural activity may be modulated not only by sex, but also by age20, pointing to the need to study the effects of pharmacological treatments in the context of sex-specific neurodevelopmental trajectories.
In NT females, greater genetic risk for ASD in the OXTR was related to reduced functional connectivity between the NAcc and anterior cingulate (ACC), and increased connectivity with medial orbital frontal cortex (OFC). Both the ACC and OFC are components of the limbic fronto-striatal circuit, which plays a role in reward processing and goal directed planning based on distant outcomes64. Neuroanatomically, when a rewarding stimulus is given (i.e., a smiling face, money, etc.), dopaminergic projections from the midbrain encode reward prediction error69 and signal to the ventral striatum and frontal cortex, which encode the subjective reward value of the stimulus70. Thus, the ventral striatum and frontal cortex form a feedback loop that is critical for implicit learning of the relationship between reward prediction and likely outcomes. Our findings in NT females suggest that variability in OXTR genotypes impact the relative balance of connectivity between nodes of the fronto-striatal loop in NT females, possibly affecting signaling from the frontal lobe back to subcortical brain regions to impact decision making based on previous reward. Notably, there are sex- and age-dependent differences in structural connectivity between the NAcc and OFC in neurotypical individuals with males showing earlier peak in structural connectivity between these two regions relative to females71. The developmental trajectory of accumbo-frontal connectivity remains to be explored in males and females with ASD and is an important future direction.
In sum, this study examined resting-state functional connectivity of the nucleus accumbens in females with and without ASD to investigate how ASD risk-allele dosage in the OXTR relates to between-subject heterogeneity in network connectivity. Critically, we investigated sex differences in the effects of genetic risk on the brain by comparing cohorts of males and females with ASD. Taken together, our results confirm previous evidence that OXTR risk variants are indeed associated with distinct neuroendophenotypes in both NT and ASD individuals. Our findings show that the specific brain regions affected and the direction of the observed effect varies as a function of both sex and ASD-diagnostic status. These findings have important implications for treatment studies investigating the effects of intranasal oxytocin on brain activity as they suggest that males and females may have different responses to pharmacological treatment depending on their genetic background and diagnostic status. More broadly, these findings underscore the importance of including females in studies investigating the neural basis of ASD, which in addition to providing insights into the etiology of ASD, can inform our understanding of how variability at the genetic, neural, and behavioral level gives rise to sex differences in rates of ASD diagnosis, and ultimately inform personalized approaches to the treatment of ASD.
Supplementary information
Acknowledgements
This work was supported by the National Institute of Neurological Disorders and Stroke (award number F99NS105206 to L.M.H.), the National Institute of Mental Health (award numbers R01MH100028 to K.A.P., F31MH110140 to K.E.L., and F32MH105167 to S.A.G.), the National Science Foundation (Graduate Research Fellowship award number 1650604 to N.T.P.), and the ARCS Foundation. We are also grateful for generous support from the Brain Mapping Medical Research Organization, Brain Mapping Support Foundation, Pierson-Lovelace Foundation, The Ahmanson Foundation, Capital Group Companies Charitable Foundation, William M. and Linda R. Dietel Philanthropic Fund, and Northstar Fund. Research reported in this publication was also partially supported by the National Center for Research Resources and by the Office of the Director of the National Institutes of Health under award numbers C06RR012169, C06RR015431, and S10OD011939. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.
Conflict of interest
The authors declare that they have no conflict of interest.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information accompanies this paper at (10.1038/s41398-020-0750-9).
References
- 1.Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 2001;81:629–683. doi: 10.1152/physrev.2001.81.2.629. [DOI] [PubMed] [Google Scholar]
- 2.Johnson ZV, Young LJ. Oxytocin and vasopressin neural networks: Implications for social behavioral diversity and translational neuroscience. Neurosci. Biobehav. Rev. 2017;76:87–98. doi: 10.1016/j.neubiorev.2017.01.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Yrigollen CM, et al. Genes controlling affiliative behavior as candidate genes for autism. Biol. Psychiatry. 2008;63:911–916. doi: 10.1016/j.biopsych.2007.11.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Wermter A-K, et al. Evidence for the involvement of genetic variation in the oxytocin receptor gene (OXTR) in the etiology of autistic disorders on high-functioning level. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 2010;153B:629–639. doi: 10.1002/ajmg.b.31032. [DOI] [PubMed] [Google Scholar]
- 5.Campbell DB, et al. Association of oxytocin receptor (OXTR) gene variants with multiple phenotype domains of autism spectrum disorder. J. Neurodev. Disord. 2011;3:101–112. doi: 10.1007/s11689-010-9071-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.LoParo D, Waldman ID. The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: a meta-analysis. Mol. Psychiatry. 2015;20:640–646. doi: 10.1038/mp.2014.77. [DOI] [PubMed] [Google Scholar]
- 7.Kosaka H, et al. Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial. Transl. Psychiatry. 2016;6:e872. doi: 10.1038/tp.2016.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Yatawara CJ, Einfeld SL, Hickie IB, Davenport TA, Guastella AJ. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial. Mol. Psychiatry. 2016;21:1225–1231. doi: 10.1038/mp.2015.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Andari, E., Hurlemann, R. & Young, L. J. A Precision Medicine Approach to Oxytocin Trials 559–590 (Springer, Cham, 2017). 10.1007/7854_2017_29. [DOI] [PMC free article] [PubMed]
- 10.Gordon I, et al. Oxytocin enhances brain function in children with autism. Proc. Natl Acad. Sci. USA. 2013;110:20953–20958. doi: 10.1073/pnas.1312857110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Watanabe T, et al. Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity. JAMA Psychiatry. 2014;71:166. doi: 10.1001/jamapsychiatry.2013.3181. [DOI] [PubMed] [Google Scholar]
- 12.Menard C, et al. Social stress induces neurovascular pathology promoting depression. Nat. Neurosci. 2017;20:1752–1760. doi: 10.1038/s41593-017-0010-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Aoki Y, et al. Oxytocin’s neurochemical effects in the medial prefrontal cortex underlie recovery of task-specific brain activity in autism: a randomized controlled trial. Mol. Psychiatry. 2015;20:447–453. doi: 10.1038/mp.2014.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Watanabe T, et al. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism. Brain. 2015;138:3400–3412. doi: 10.1093/brain/awv249. [DOI] [PubMed] [Google Scholar]
- 15.Gordon I, et al. Intranasal oxytocin enhances connectivity in the neural circuitry supporting social motivation and social perception in children with autism. Sci. Rep. 2016;6:35054. doi: 10.1038/srep35054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Greene RK, et al. The effects of intranasal oxytocin on reward circuitry responses in children with autism spectrum disorder. J. Neurodev. Disord. 2018;10:12. doi: 10.1186/s11689-018-9228-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Baio J, et al. Prevalence of autism spectrum disorder among children aged 8 years — autism and developmental disabilities monitoring network, 11 sites, United States, 2014. Mmwr. Surveill. Summ. 2018;67:1–23. doi: 10.15585/mmwr.ss6706a1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Dumais KM, Veenema AH. Vasopressin and oxytocin receptor systems in the brain: Sex differences and sex-specific regulation of social behavior. Front. Neuroendocrinol. 2016;40:1–23. doi: 10.1016/j.yfrne.2015.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Kramer KM, Cushing BS, Carter CS, Wu J, Ottinger MA. Sex and species differences in plasma oxytocin using an enzyme immunoassay. Can. J. Zool. 2004;82:1194–1200. [Google Scholar]
- 20.Ebner NC, et al. Oxytocin’s effect on resting-state functional connectivity varies by age and sex. Psychoneuroendocrinology. 2016;69:50–59. doi: 10.1016/j.psyneuen.2016.03.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Mitre M, et al. A distributed network for social cognition enriched for oxytocin receptors. J. Neurosci. 2016;36:2517–2535. doi: 10.1523/JNEUROSCI.2409-15.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Mitre M, et al. Sex-specific differences in oxytocin receptor expression and function for parental behavior. Gend. Genome. 2017;1:1–25. doi: 10.1089/gg.2017.0017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.King LB, Walum H, Inoue K, Eyrich NW, Young LJ. Variation in the Oxytocin Receptor Gene Predicts Brain Region-Specific Expression and Social Attachment. Biol. Psychiatry. 2016;80:160–169. doi: 10.1016/j.biopsych.2015.12.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Dubrovsky B, Harris J, Gijsbers K, Tatarinov A. Oxytocin induces long-term depression on the rat dentate gyrus: possible ATPase and ectoprotein kinase mediation. Brain Res. Bull. 2002;58:141–147. doi: 10.1016/s0361-9230(01)00748-1. [DOI] [PubMed] [Google Scholar]
- 25.Gur R, Tendler A, Wagner S. Long-term social recognition memory is mediated by oxytocin-dependent synaptic plasticity in the medial amygdala. Biol. Psychiatry. 2014;76:377–386. doi: 10.1016/j.biopsych.2014.03.022. [DOI] [PubMed] [Google Scholar]
- 26.Tomizawa K, et al. Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade. Nat. Neurosci. 2003;6:384–390. doi: 10.1038/nn1023. [DOI] [PubMed] [Google Scholar]
- 27.Yuan L, et al. Oxytocin inhibits lipopolysaccharide-induced inflammation in microglial cells and attenuates microglial activation in lipopolysaccharide-treated mice. J. Neuroinflammation. 2016;13:77. doi: 10.1186/s12974-016-0541-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Dölen G, Darvishzadeh A, Huang KW, Malenka RC. Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin. Nature. 2013;501:179–184. doi: 10.1038/nature12518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Mairesse J, et al. Oxytocin receptor agonist reduces perinatal brain damage by targeting microglia. Glia. 2019;67:345–359. doi: 10.1002/glia.23546. [DOI] [PubMed] [Google Scholar]
- 30.Carter CS. Sex differences in oxytocin and vasopressin: implications for autism spectrum disorders? Behav. Brain Res. 2007;176:170–186. doi: 10.1016/j.bbr.2006.08.025. [DOI] [PubMed] [Google Scholar]
- 31.Robinson EB, Lichtenstein P, Anckarsäter H, Happé F, Ronald A. Examining and interpreting the female protective effect against autistic behavior. Proc. Natl Acad. Sci. USA. 2013;110:5258–5262. doi: 10.1073/pnas.1211070110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Sanders SJ, et al. Multiple recurrent de novo cnvs, including duplications of the 7q11.23 williams syndrome region, are strongly associated with autism. Neuron. 2011;70:863–885. doi: 10.1016/j.neuron.2011.05.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Jacquemont S, et al. A higher mutational burden in females supports a “Female Protective Model” in neurodevelopmental disorders. Am. J. Hum. Genet. 2014;94:415–425. doi: 10.1016/j.ajhg.2014.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Werling DM, Parikshak NN, Geschwind DH. Gene expression in human brain implicates sexually dimorphic pathways in autism spectrum disorders. Nat. Commun. 2016;7:10717. doi: 10.1038/ncomms10717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Werling DM. The role of sex-differential biology in risk for autism spectrum disorder. Biol. Sex. Differ. 2016;7:58. doi: 10.1186/s13293-016-0112-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Mottron L, et al. Sex differences in brain plasticity: a new hypothesis for sex ratio bias in autism. Mol. Autism. 2015;6:33. doi: 10.1186/s13229-015-0024-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Bourgeron T. From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat. Rev. Neurosci. 2015;16:551–563. doi: 10.1038/nrn3992. [DOI] [PubMed] [Google Scholar]
- 38.Damiano CR, et al. Association between the oxytocin receptor (OXTR) gene and mesolimbic responses to rewards. Mol. Autism. 2014;5:7. doi: 10.1186/2040-2392-5-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Bethlehem RAI, et al. Intranasal oxytocin enhances intrinsic corticostriatal functional connectivity in women. Transl. Psychiatry. 2017;7:e1099. doi: 10.1038/tp.2017.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Supekar, K. et al. Deficits in mesolimbic reward pathway underlie social interaction impairments in children with autism. Brain. 10.1093/brain/awy191 (2018). [DOI] [PMC free article] [PubMed]
- 41.Scott-Van Zeeland AA, Dapretto M, Ghahremani DG, Poldrack RA, Bookheimer SY. Reward processing in autism. Autism Res. 2010;3:n/a–n/a. doi: 10.1002/aur.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Dichter GS, Richey JA, Rittenberg AM, Sabatino A, Bodfish JW. Reward circuitry function in autism during face anticipation and outcomes. J. Autism Dev. Disord. 2012;42:147–160. doi: 10.1007/s10803-011-1221-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Kohls G, et al. Reward system dysfunction in autism spectrum disorders. Soc. Cogn. Affect. Neurosci. 2013;8:565–572. doi: 10.1093/scan/nss033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Delmonte S, et al. Social and monetary reward processing in autism spectrum disorders. Mol. Autism. 2012;3:7. doi: 10.1186/2040-2392-3-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Hernandez, L. M. et al. Additive effects of oxytocin receptor gene polymorphisms on reward circuitry in youth with autism. Mol. Psychiatry22, 1134–1139 (2017). [DOI] [PMC free article] [PubMed]
- 46.American Psychological Assocaition. Diagnostic and statistical manual of mental disorders. 5th edn. (American Psychological Assocaition, 2013).
- 47.Lord, C. et al. Autism Diagnostic Observation Schedule 2nd edn. (Western Psychological Services, Torrance, 2012).
- 48.Lord C, Rutter M, Le Couteur A. Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J. Autism Dev. Disord. 1994;24:659–685. doi: 10.1007/BF02172145. [DOI] [PubMed] [Google Scholar]
- 49.Beran, T. N. Elliott, C. D. (2007). Differential Ability Scales (2nd ed.). Can. J. Sch. Psychol. 22, 128–132 (Harcourt Assessment, San Antonio, TX, 2007).
- 50.Wechsler, D. The Wechsler Intelligence Scale For Children. (Psychological Corporation, New York, NY, 1991).
- 51.Wechsler, D. Wechsler Abbreviated Scale of Intelligence. (NCS Pearson, San Antonio, TX, 1999).
- 52.Constantino, J. & Gruber, C. Social Responsiveness Scale (SRS) Manual. (Western Psychological Services, Los Angeles, 2005).
- 53.Smith SM, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004;23:S208–S219. doi: 10.1016/j.neuroimage.2004.07.051. [DOI] [PubMed] [Google Scholar]
- 54.Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput. Biomed. Res. 1996;29:162–173. doi: 10.1006/cbmr.1996.0014. [DOI] [PubMed] [Google Scholar]
- 55.Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage. 2002;17:825–841. doi: 10.1016/s1053-8119(02)91132-8. [DOI] [PubMed] [Google Scholar]
- 56.Power JD, Barnes KA, Snyder AZ, Schlaggar BL, Petersen SE. Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage. 2012;59:2142–2154. doi: 10.1016/j.neuroimage.2011.10.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Faul F, Erdfelder E, Buchner A, Lang A-G. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav. Res. Methods. 2009;41:1149–1160. doi: 10.3758/BRM.41.4.1149. [DOI] [PubMed] [Google Scholar]
- 58.Voineagu I, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature. 2011;474:380–384. doi: 10.1038/nature10110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Skuse DH, et al. Social communication competence and functional adaptation in a general population of children: preliminary evidence for sex-by-verbal IQ differential risk. J. Am. Acad. Child Adolesc. Psychiatry. 2009;48:128–137. doi: 10.1097/CHI.0b013e31819176b8. [DOI] [PubMed] [Google Scholar]
- 60.Lai M-C, et al. A behavioral comparison of male and female adults with high functioning autism spectrum conditions. PLoS ONE. 2011;6:e20835. doi: 10.1371/journal.pone.0020835. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Mandy W, et al. Sex differences in autism spectrum disorder: evidence from a large sample of children and adolescents. J. Autism Dev. Disord. 2012;42:1304–1313. doi: 10.1007/s10803-011-1356-0. [DOI] [PubMed] [Google Scholar]
- 62.Halladay AK, et al. Sex and gender differences in autism spectrum disorder: summarizing evidence gaps and identifying emerging areas of priority. Mol. Autism. 2015;6:36. doi: 10.1186/s13229-015-0019-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.DeLong M, Wichmann T. Changing views of basal ganglia circuits and circuit disorders. Clin. EEG Neurosci. 2010;41:61–67. doi: 10.1177/155005941004100204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 1986;9:357–381. doi: 10.1146/annurev.ne.09.030186.002041. [DOI] [PubMed] [Google Scholar]
- 65.Szatmari P, et al. Sex differences in repetitive stereotyped behaviors in autism: Implications for genetic liability. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 2012;159B:5–12. doi: 10.1002/ajmg.b.31238. [DOI] [PubMed] [Google Scholar]
- 66.Feng C, et al. Oxytocin and vasopressin effects on the neural response to social cooperation are modulated by sex in humans. Brain Imaging Behav. 2015;9:754–764. doi: 10.1007/s11682-014-9333-9. [DOI] [PubMed] [Google Scholar]
- 67.Feng C, et al. A common oxytocin receptor gene (OXTR) polymorphism modulates intranasal oxytocin effects on the neural response to social cooperation in humans. Genes. Brain. Behav. 2015;14:516–525. doi: 10.1111/gbb.12234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Waller R, et al. An oxytocin receptor polymorphism predicts amygdala reactivity and antisocial behavior in men. Soc. Cogn. Affect. Neurosci. 2016;11:1218–1226. doi: 10.1093/scan/nsw042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Rodriguez PF, Aron AR, Poldrack RA. Ventral–striatal/nucleus–accumbens sensitivity to prediction errors during classification learning. Hum. Brain Mapp. 2006;27:306–313. doi: 10.1002/hbm.20186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Montague PR, Dayan P, Sejnowski TJ. A framework for mesencephalic dopamine systems based on predictive Hebbian learning. J. Neurosci. 1996;16:1936–1947. doi: 10.1523/JNEUROSCI.16-05-01936.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Karlsgodt KH, et al. The accumbofrontal tract: diffusion tensor imaging characterization and developmental change from childhood to adulthood. Hum. Brain Mapp. 2015;36:4954–4963. doi: 10.1002/hbm.22989. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.